Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)
European Journal of Cancer2017Vol. 83, pp. 177–184
Citations Over TimeTop 10% of 2017 papers
Julia Chisholm, Johannes H. M. Merks, Michela Casanova, Gianni Bisogno, Daniel Orbach, Jean-Claude Gentet, Anne Sophie Defachelles, Pascal Chastagner, Stephen P. Lowis, Milind Ronghe, Kieran McHugh, Rick R. van Rijn, Magalie Hilton, Jeanette Bachir, Sabine Fürst‐Recktenwald, Birgit Geoerger, Odile Oberlin
Related Papers
- → Preclinical Analysis of Tasidotin HCl in Ewing's Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma, and Osteosarcoma(2007)23 cited
- → Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma(1997)20 cited
- → Expression of interleukin 15 (IL‐15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma(1997)1 cited
- → The Management of Musculoskeletal Tumours(1977)
- → Maintenance Low-Dose Chemotherapy in High-Risk Rhabdomyosarcoma(2018)